ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. (603976.SS)
CNY 17.17
(-0.58%)
CNY 17.17
(-0.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 194.19 Million | 38.42 Million | 104.96 Million | 121.79 Million | 55.27 Million | 64.29 Million |
| Net Income | 40.26 Million | 64.76 Million | 106.6 Million | 53.05 Million | 61.05 Million | 82.76 Million |
| Depreciation & Amortization | 105.69 Million | 86.46 Million | 66.8 Million | 53.49 Million | 51.36 Million | 48.27 Million |
| Deferred income taxes | -16.89 Million | 7.74 Million | -5.01 Million | -71.24 Thousand | -289.99 Thousand | -702.89 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 29.1 Million | -147.03 Million | -85.68 Million | 11.79 Million | -59.27 Million | -71.2 Million |
| Other non-cash items | 22.89 Million | 34.23 Million | 17.23 Million | 3.45 Million | 2.13 Million | 4.46 Million |
| Investing Cash Flow | -176.75 Million | -169.03 Million | -385.88 Million | -141.94 Million | -155.55 Million | -69.19 Million |
| Investments in PPE | -89.97 Million | -276.09 Million | -137.54 Million | -175.89 Million | -111.65 Million | -69.19 Million |
| Acquisitions | 40.99 Thousand | 0.19 | 151.99 Thousand | 47 Thousand | 43.9 Million | - |
| Investment purchases | -790 Million | -460 Million | -450 Million | - | -44.33 Million | - |
| Sales/Maturities of investments | 705.9 Million | 558.26 Million | 201.3 Million | - | 434.86 Thousand | - |
| Other Investing Activities | -2.73 Million | 8.78 Million | 205.4 Thousand | 33.9 Million | -43.9 Million | -69.19 Million |
| Financing Cash Flow | -43.64 Million | -33.9 Million | 387.09 Million | -1.43 Million | -12.09 Million | -49.68 Million |
| Debt repayment | -30 Million | -50 Million | -49.7 Million | -47.87 Million | - | - |
| Dividends payments | -8.96 Million | -46.57 Million | -5.44 Million | -48.62 Million | -12.09 Million | -49.68 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -319.5 Thousand | 65.74 Million | 442.99 Million | 95.74 Million | - | - |
| Accounts receivables | -57.42 Million | -109.63 Million | -188.46 Million | -35.63 Million | -54.46 Million | -77.97 Million |
| Accounts payables | 93.27 Million | -12.67 Million | 153.32 Million | 53.96 Million | 23.66 Million | 17.51 Million |
| Inventory | 10.15 Million | -32.47 Million | -45.51 Million | -6.45 Million | -28.19 Million | -10.05 Million |
| Other working capital | 76.38 Million | 7.74 Million | -5.01 Million | -71.24 Thousand | -289.99 Thousand | -61.15 Million |
| Cash at beginning of period | 183.43 Million | 347.78 Million | 241.61 Million | 263.19 Million | 375.57 Million | 430.15 Million |
| Cash at end of period | 157.25 Million | 183.43 Million | 347.78 Million | 241.61 Million | 263.19 Million | 375.57 Million |
| Capital Expenditure | -89.97 Million | -276.09 Million | -137.54 Million | -175.89 Million | -111.65 Million | -69.19 Million |
| Effect of forex changes on cash | 19.44 Thousand | 163.81 Thousand | -9399.80 | - | - | - |
| Net cash flow / Change in cash | -26.18 Million | -164.35 Million | 106.16 Million | -21.57 Million | -112.37 Million | -54.57 Million |
| Free Cash Flow | 104.22 Million | -237.66 Million | -32.58 Million | -54.09 Million | -56.37 Million | -4.89 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.56 Million | 23.33 Million | 21.04 Million | 40.26 Million | 4.55 Million | 5.14 Million |
| Depreciation & Amortization | - | 29.81 Million | 29.81 Million | 105.69 Million | 27.78 Million | -50.78 Million |
| Deferred income taxes | - | - | - | -16.89 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -42.09 Million | - | 29.1 Million | -47.27 Million | 19.24 Million |
| Other non-cash items | 49.28 Million | 35.12 Million | -16.42 Million | 22.89 Million | 130.58 Million | 69.38 Million |
| Investing Cash Flow | -26.54 Million | 156.47 Million | 15.51 Million | -176.75 Million | -137.54 Million | 12.52 Million |
| Investments in PPE | -10.35 Million | -11.04 Million | -31.32 Million | -89.97 Million | -46.26 Million | -12.3 Million |
| Acquisitions | - | - | - | 40.99 Thousand | 40.99 Thousand | - |
| Investment purchases | -50 Million | -170 Million | - | -790 Million | -420 Million | -150 Million |
| Sales/Maturities of investments | 30.68 Million | 340 Million | 50.41 Million | 705.9 Million | 331.85 Million | 173.21 Million |
| Other Investing Activities | 3.12 Million | -2.48 Million | -3.56 Million | -2.73 Million | -3.17 Million | 1.61 Million |
| Financing Cash Flow | -45.28 Million | -35.33 Million | -261.44 Thousand | -43.64 Million | -30.4 Million | -411.26 Thousand |
| Debt repayment | - | - | - | -30 Million | -30 Million | -30 Million |
| Dividends payments | -15.21 Million | -35.27 Million | -189.58 Thousand | -8.96 Million | -307.79 Thousand | -349.99 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -30.07 Million | -35.2 Million | -71.85 Thousand | -319.5 Thousand | -101.46 Thousand | 29.93 Million |
| Accounts receivables | - | -16.55 Million | - | -57.42 Million | -57.42 Million | 29.07 Million |
| Accounts payables | - | - | - | 93.27 Million | - | - |
| Inventory | - | -25.53 Million | - | 10.15 Million | 10.15 Million | -9.83 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 326.9 Million | 208.08 Million | 157.25 Million | 183.43 Million | 219.68 Million | 167.79 Million |
| Cash at end of period | 311.23 Million | 372.34 Million | 177.12 Million | 157.25 Million | 157.25 Million | 219.68 Million |
| Capital Expenditure | -10.35 Million | -11.04 Million | -31.32 Million | -89.97 Million | -46.26 Million | -12.3 Million |
| Effect of forex changes on cash | - | - | - | 19.44 Thousand | 19.44 Thousand | -3.21 Million |
| Net cash flow / Change in cash | -15.66 Million | 164.25 Million | 19.87 Million | -26.18 Million | -62.43 Million | 51.89 Million |
| Free Cash Flow | 46.49 Million | 17.6 Million | -26.71 Million | 104.22 Million | 61.09 Million | 30.69 Million |
CLIS
ADXN
CHRTEDCA
HPIFY
688062
8961